¶ ReNAgade Therapeutics
.png)
ReNAgade Therapeutics is an American biotechnology company based in Cambridge, Massachusetts.
¶ Personnel
| Name | Position | Notes |
|---|---|---|
| Amit Munshi | Chief Executive Officer | Arena Pharmaceuticals |
| Peter Smith | Chief Scientific Officer | Alnylam Pharmaceuticals, Moderna, Millennium Pharmaceuticals |
| Brian Shuster | Chief Business Officer | JPMorgan Chase, Johnson & Johnson |
| Ciaran Lawlor | Chief Operating Officer | Boston Consulting Group (BCG), Moderna |
| Ansbert Gadicke | Co-founder | - |
| Morana Jovan-Embiricos | Board member | F2 Ventures |
| Brian Goodman | Board member | MPM BioImpact |
| Matt Roden | Board member, Co-founder | MPM BioImpact |
¶ Investors
Investors in ReNAgade Therapeutics include:[1]
- Alexandria Venture Investments
- F2 Ventures
- MPM BioImpact
¶ External links
Team. ReNAgade Therapeutics. Retrieved June 14, 2023, from https://web.archive.org/web/20230614231455/https://renagadetx.com/team/ ↩︎